Cargando…

Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis

BACKGROUND: Psoriasis is a chronic inflammatory skin disease associated with several important medical comorbidities. There are scant data available on the comorbidities of patients with psoriasis in South America. AIM: To examine the comorbidity profile of adult patients with psoriasis in Chile and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenzuela, Fernando, De La Cruz, Claudia, Lecaros, Cristóbal, Fernández, Javier, Hevia, Gonzalo, Maul, Lara Valeska, Thyssen, Jacob P., Vera‐Kellet, Cristián, Egeberg, Alexander, Armijo, Daniela, Pizarro, Cristian, Riveros, Tatiana, Correa, Hernán, Guglielmetti, Antonio, Didaskalu, Johannes A., Wu, Jashin J., Griffiths, Christopher E. M., Romiti, Ricardo, Maul, Julia‐Tatjana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092698/ https://www.ncbi.nlm.nih.gov/pubmed/35988043 http://dx.doi.org/10.1111/ced.15384

Ejemplares similares

The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis
por: Guillet, Carole, et al.
Publicado: (2022)

Adalimumab for severe psoriasis in Chilean paediatric patients()()
por: Armijo Fernandez, Daniela, et al.
Publicado: (2020)

The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
por: Lecaros, C., et al.
Publicado: (2021)

Beauty and the Biologic: Artistic Documentation of Scientific Breakthrough in Psoriasis
por: Maul, Julia-Tatjana, et al.
Publicado: (2015)

The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
por: Wu, Jashin J., et al.
Publicado: (2022)

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort
por: Egeberg, Alexander, et al.
Publicado: (2019)

Psoriasis and Co-morbidity
por: AMIN, Mina, et al.
Publicado: (2020)

Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis
por: Anzengruber, Florian, et al.
Publicado: (2018)

Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
por: Travaglini, Massimo, et al.
Publicado: (2023)

BDNF and Cognitive Function in Chilean Schizophrenic Patients
por: Nieto, Rodrigo R., et al.
Publicado: (2023)

Diagnosis of Generalized Pustular Psoriasis
por: Fujita, Hideki, et al.
Publicado: (2022)

Psoriasis comorbidities: complications and benefits of immunobiological treatment
por: de Carvalho, André Vicente Esteves, et al.
Publicado: (2016)

The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
por: Ring, Hans Christian, et al.
Publicado: (2022)

Economic Burden of Comorbidities in Patients with Psoriasis in the USA
por: Wu, Jashin J., et al.
Publicado: (2022)

Generalized pustular psoriasis (von Zumbusch)()
por: Romiti, Ricardo, et al.
Publicado: (2022)

Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy
por: Pithadia, Deeti J., et al.
Publicado: (2019)

Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease
por: Navarrete-Dechent, Cristián, et al.
Publicado: (2015)

Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis
por: Nițescu, Diana Ana-Maria, et al.
Publicado: (2022)

No impact of disease duration on response to tildrakizumab treatment among patients with moderate‐to‐severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studies
por: Griss, Johannes, et al.
Publicado: (2023)

Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
por: Manalo, Iviensan F, et al.
Publicado: (2015)

Skin Recovery After Discontinuation of Long-Term Moisturizer Application: A Split-Face Comparison Pilot Study
por: Maul, Julia-Tatjana, et al.
Publicado: (2020)

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
por: Wu, Jashin J., et al.
Publicado: (2020)

Development and internal validation of a diagnostic prediction model for psoriasis severity
por: Liljendahl, Mie Sylow, et al.
Publicado: (2023)

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Kirkham, Bruce W., et al.
Publicado: (2023)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
por: Egeberg, Alexander, et al.
Publicado: (2020)

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis
por: Sarma, Nilendu
Publicado: (2017)

Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study
por: Hermann, Nicola, et al.
Publicado: (2022)

Brazilian Consensus on Psoriasis 2020 and Treatment Algorithm of the Brazilian Society of Dermatology()()
por: Romiti, Ricardo, et al.
Publicado: (2021)

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
por: Egeberg, Alexander, et al.
Publicado: (2023)

Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities
por: Jeon, Caleb, et al.
Publicado: (2017)

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
por: Wu, Jashin J., et al.
Publicado: (2020)

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
por: Egeberg, A., et al.
Publicado: (2020)

Clinical Goals and Barriers to Effective Psoriasis Care
por: Strober, Bruce E., et al.
Publicado: (2018)

Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
por: Lynde, Charles, et al.
Publicado: (2022)

Inverse Psoriasis Involving Genital Skin Folds: Successful Therapy with Dapsone
por: Guglielmetti, Antonio, et al.
Publicado: (2012)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021)

Effect Modification by Smoking Status on the Association Between Psoriasis and Chronic Obstructive Pulmonary Disease among Adults in the USA
por: LIU, Jeffrey, et al.
Publicado: (2021)

Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese
por: de Morais, Marina Resener, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vnsq5kj2p6edfl8ioi1gqu8msm